Výsledky vyhledávání - "Valentine Verdier"

Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity

Autor: Jean Louis Bonnet, Pierre Deharo, Thomas W Johnson, Pierre Suchon, C. Bassez, L. Fourcade, Marianne Fernandez, Jacques Quilici, Marie-Christine Alessi, Guillaume Bonnet, Valentine Verdier, Pierre-Emmanuel Morange, Laurence Camoin-Jau, Thomas Cuisset, Manal Ibrahim

Publikováno v: JACC: Cardiovascular Interventions. 10:2560-2570

Objectives: This study sought to evaluate the impact of initial platelet reactivity on the benefit of switched strategy. Background: TOPIC (Timing Of Platelet Inhibition after acute Coronary Syndrome) study suggested that switched dual antiplatelet t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c819dd625df31b6a208e63244b98ac9c
https://doi.org/10.1016/j.jcin.2017.08.044

Zobrazit plný text záznamu

Language, intellectual and educational outcomes after moderate-to-severe traumatic brain injury sustained before the age of 18 months

Autor: Stéphanie Rasquier, Valentine Verdier, Mathilde Chevignard, Jeanne Vassel-Hitier, Anne Laurent-Vannier, Anaïs Chalard

Publikováno v: Brain injury. 33(8)

Objective: The aim of this study was to assess long-term outcomes in terms of oral language, intellectual ability, education, following very early moderate-to-severe TBI. Methods: Children who had been hospitalized in rehabilitation after moderate-to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::877208b9667c01c49ec8b6dbbb34ae7e
https://pubmed.ncbi.nlm.nih.gov/31165657

Zobrazit plný text záznamu

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

Autor: Marc Lambert, C. Bassez, Stéphanie Deffarges, Valentine Verdier, Pierre Deharo, Thomas Cuisset, L. Fourcade, Jean Philippe Mouret, Thomas W Johnson, Jacques Quilici, Pierre-Emmanuel Morange, Marie-Christine Alessi, Jean Louis Bonnet, Guillaume Bonnet

Publikováno v: European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩
European Heart Journal, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩

Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant ischaemic benefit over clopidogrel after acute coronary syndrome (ACS). However, both drugs are associated with an increase in bleeding complications. The objective of the prese

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b54aa4f89e8565fb0ee95aaacb7e3c
https://pubmed.ncbi.nlm.nih.gov/31039217

Zobrazit plný text záznamu

Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting

Autor: Marie-Christine Alessi, Guillaume Bonnet, Anderson Diendonné Loundou, Bénédicte Gaborit, Anne Dutour, Jean-Louis Bonnet, Pierre Deharo, Pierre-Emmanuel Morange, Valentine Verdier, Jacques Quilici, Mathieu Pankert, Thomas Cuisset, René Valéro, Marc Lambert

Publikováno v: American Journal of Cardiology
American Journal of Cardiology, Elsevier, 2014, 113 (1), pp.54-59. ⟨10.1016/j.amjcard.2013.09.011⟩

International audience; This study aimed to analyze the impact of body mass index (BMI) and the metabolic syndrome (MS) on responses to clopidogrel or prasugrel and bleeding risk after acute coronary syndrome. The study included 1,542 consecutive pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353b308d70719c8ab41cbe06d563a011
https://hal.inrae.fr/hal-02634118

Zobrazit plný text záznamu

Prasugrel versus ticagrelor in acute coronary syndrome: A randomized comparison

Autor: Valentine Verdier, Pierre Morange, Pierre Deharo, Marie-Christine Alessi, C. Bassez, Mathieu Pankert, Thomas Cuisset, Guillaume Bonnet, Marc Lambert, Jean-Louis Bonnet, Jacques Quilici

Publikováno v: International Journal of Cardiology
International Journal of Cardiology, 2013, 170 (2), pp.E21-E22. ⟨10.1016/j.ijcard.2013.10.043⟩
International Journal of Cardiology, Elsevier, 2013, 170 (2), pp.E21-E22. ⟨10.1016/j.ijcard.2013.10.043⟩

International audience; Dual antiplatelet therapy with Aspirin and Clopidogrel has been considered as a cornerstone therapy after acute coronary syndrome (ACS) [1] before new P2Y12 blockers demonstrated their clinical benefit in large randomized cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247c090f00644ec73c6695a9b082db90
https://doi.org/10.1016/j.ijcard.2013.10.043

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání